THIOTEPA (thiotepa)
- Carcinoma of breast
- Conditioning prior to allogeneic stem cell transplant
- Malignant ascites
- Malignant neoplasm of the ovary
- Malignant tumor of urinary bladder
- Pericardial malignant effusions
- Pleural malignant effusions
100 mg solution for injection
- Dosage information is not available
15 mg solution for injection
- Dosage information is not available
100 mg solution for injection
- Dosage information is not available
15 mg solution for injection
- Dosage information is not available
Carcinoma of breast
- Inject 0.3 mg/kg by intravenous route once weekly
- Inject 0.3 mg/kg by intravenous route every 4 weeks
- Inject 0.4 mg/kg by intravenous route once weekly
- Inject 0.4 mg/kg by intravenous route every 4 weeks
Malignant ascites
- Instill 0.6 mg/kg by intracavity route once weekly
- Instill 0.6 mg/kg by intracavity route every 4 weeks
- Instill 0.8 mg/kg by intracavity route once weekly
- Instill 0.8 mg/kg by intracavity route every 4 weeks
Malignant neoplasm of the ovary
- Inject 0.3 mg/kg by intravenous route once weekly
- Inject 0.3 mg/kg by intravenous route every 4 weeks
- Inject 0.4 mg/kg by intravenous route once weekly
- Inject 0.4 mg/kg by intravenous route every 4 weeks
Malignant tumor of urinary bladder
- Instill 60 mg into bladder via catheter by intravesical route once weekly ;Retain in bladder for 2 hours
- Instill 60 mg into bladder via catheter by intravesical route once weekly for 4 weeks ;Retain in bladder for 2 hours
Pericardial malignant effusions
- Instill 0.6 mg/kg by intracavity route once weekly
- Instill 0.6 mg/kg by intracavity route every 4 weeks
- Instill 0.8 mg/kg by intracavity route once weekly
- Instill 0.8 mg/kg by intracavity route every 4 weeks
Pleural malignant effusions
- Instill 0.6 mg/kg by intracavity route once weekly
- Instill 0.6 mg/kg by intracavity route every 4 weeks
- Instill 0.8 mg/kg by intracavity route once weekly
- Instill 0.8 mg/kg by intracavity route every 4 weeks
- zoster vaccine live (PF)
- Zostavax (pf)
- Yf-vax (pf)
- yellow fever vaccine live (PF)
- Vivotif Berna Vaccine
- Varivax (pf)
- varicella virus vacc live (PF)
- Tysabri
- typhoid vaccine
- rotavirus vaccine live, penta
- Rotateq Vaccine
- Proquad (pf)
- natalizumab
- measles,mumps,rub,varicel(PF)
- measles,mumps&rubella vacc(PF)
- M-m-r Ii (pf)
- Flumist 2013-2014
- flu vac,qval 2013-14 (2-49yrs)
- BCG vaccine, live (PF)
- adenovirus vaccine live type-7
- adenovirus vaccine live type-4
- adenovirus vac live type-4 & 7
Contraindicated
- Versacloz
- Ferriprox
- Fazaclo
- deferiprone
- Clozaril
- clozapine
Severe
Moderate
- None
- Lactating mother
- Severe infection
Contraindicated
- Anemia
- Bone marrow depression
- Disease of liver
- Increased risk of bleeding
- Leukopenia
- Pregnancy
- Thrombocytopenic disorder
Severe
Moderate
- Chronic kidney disease stage 4 (severe) GFR 15-29 ml/min
- Chronic kidney disease stage 5 (failure) GFr<15 ml/min
THIOTEPA (thiotepa)
- Carcinoma of breast
- Conditioning prior to allogeneic stem cell transplant
- Malignant ascites
- Malignant neoplasm of the ovary
- Malignant tumor of urinary bladder
- Pericardial malignant effusions
- Pleural malignant effusions
- Abnormal hepatic function tests
- Anemia
- Cytomegalovirus disease
- Hemorrhage
- Hyperbilirubinemia
- Infection
- Leukopenia
- Neutropenic disorder
- Stomatitis
- Thrombocytopenic disorder
- Diarrhea
- Hematuria
- Skin rash
More Frequent
Severe
Less Severe
- Hyperuricemia
- Immunosuppression
- Injection site sequelae
- Intracranial bleeding
- Acute abdominal pain
- Alopecia
- Amenorrhea
- Anorexia
- Blurred vision
- Conjunctivitis
- Dizziness
- Dyschromia
- Fatigue
- Fever
- General weakness
- Headache disorder
- Irregular menstrual periods
- Nausea
- Oligospermia
- Pruritus of skin
- Skin inflammation
- Urinary retention
- Urticaria
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Ascites
- Blistering skin
- Bradycardia
- Cerebrovascular accident
- Chronic heart failure
- Coma
- Cystitis
- Dyspnea
- Encephalopathy
- Enterocolitis
- Hemorrhagic cystitis
- Hepatic veno-occlusive disease
- Hepatomegaly
- Laryngeal edema
- Leukemia
- Malignant lymphoma
- Multiple organ failure
- Pericardial effusion
- Pericarditis
- Post-transplant lymphoproliferative disease
- Pulmonary hypertension
- Renal failure
- Seizure disorder
- Stevens-johnson syndrome
- Subdural intracranial hemorrhage
- Suicidal ideation
- Toxic epidermal necrolysis
- Vision loss
- Wheezing
Less Severe
- Abnormal desquamation
- Acute confusion
- Allergic dermatitis
- Asthma
- Behavioral disorders
- Blepharoptosis
- Bradykinesia
- Delirium
- Depression
- Drowsy
- Dysphagia
- Dysuria
- Gait abnormality
- Gastritis
- Hallucinations
- Hearing loss
- Indifference
- Malaise
- Memory impairment
Contraindicated
None
Severe Precaution
Thiotepa
Increased risk of CNS toxicity (seizure, intracranial hemorrhage). No safety and efficacy established in neonates.
Increased risk of CNS toxicity (seizure, intracranial hemorrhage).
- 1 Day – 29 Days
- Increased risk of CNS toxicity (seizure, intracranial hemorrhage). No safety and efficacy established in neonates.
- Increased risk of CNS toxicity (seizure, intracranial hemorrhage).
- 30 Days – 18 Years
- Increased risk of CNS toxicity (seizure, intracranial hemorrhage). No safety and efficacy established in neonates.
- Increased risk of CNS toxicity (seizure, intracranial hemorrhage).
Management or Monitoring Precaution
None
Thiotepa
- Severity Level:
D
- Additional Notes: Based on drug pharmacology developmental toxicity is possible.
Contraindicated
Thiotepa
Tumorigenic in animal studies; molecular wt low enough for possible excretion
General | Excretion Potential | Effect on Infant | Notes |
Drug should not be given to breast feeding mothers | Unknown | Not known; no or inclusive data | Tumorigenic in animal studies; molecular wt low enough for possible excretion |
Precaution Exists
None
General | Excretion Potential | Effect on Infant | Notes |
None |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
Thiotepa
General - Monitor carefully. Dose reduction may be necessary.
Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
Increased Risk / Adverse Effects | Y | N | N | N | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- This medication decreases bone marrow function, an effect that may lead to a low number of blood cells such as red cells, white cells, and platelets. This effect can cause anemia, decrease your body's ability to fight an infection, or cause easy bruising/bleeding. A certain lab test (complete blood count) should be done while you are using this medication.<br /><br />Tell your doctor right away if you develop any of the following symptoms: unusual tiredness, pale skin, signs of infection (such as sore throat that doesn't go away, fever, chills), easy bruising/bleeding. See also How to Use and Side Effects sections. Although thiotepa is used to treat cancer, in some people this medication may also increase the risk of developing another form of cancer. Talk to your doctor about the risks and benefits of this medication.
Carcinoma of breast | |
C50 | Malignant neoplasm of breast |
C50.1 | Malignant neoplasm of central portion of breast |
C50.11 | Malignant neoplasm of central portion of breast, female |
C50.111 | Malignant neoplasm of central portion of right female breast |
C50.112 | Malignant neoplasm of central portion of left female breast |
C50.119 | Malignant neoplasm of central portion of unspecified female breast |
C50.12 | Malignant neoplasm of central portion of breast, male |
C50.121 | Malignant neoplasm of central portion of right male breast |
C50.122 | Malignant neoplasm of central portion of left male breast |
C50.129 | Malignant neoplasm of central portion of unspecified male breast |
C50.2 | Malignant neoplasm of upper-inner quadrant of breast |
C50.21 | Malignant neoplasm of upper-inner quadrant of breast, female |
C50.211 | Malignant neoplasm of upper-inner quadrant of right female breast |
C50.212 | Malignant neoplasm of upper-inner quadrant of left female breast |
C50.219 | Malignant neoplasm of upper-inner quadrant of unspecified female breast |
C50.22 | Malignant neoplasm of upper-inner quadrant of breast, male |
C50.221 | Malignant neoplasm of upper-inner quadrant of right male breast |
C50.222 | Malignant neoplasm of upper-inner quadrant of left male breast |
C50.229 | Malignant neoplasm of upper-inner quadrant of unspecified male breast |
C50.3 | Malignant neoplasm of lower-inner quadrant of breast |
C50.31 | Malignant neoplasm of lower-inner quadrant of breast, female |
C50.311 | Malignant neoplasm of lower-inner quadrant of right female breast |
C50.312 | Malignant neoplasm of lower-inner quadrant of left female breast |
C50.319 | Malignant neoplasm of lower-inner quadrant of unspecified female breast |
C50.32 | Malignant neoplasm of lower-inner quadrant of breast, male |
C50.321 | Malignant neoplasm of lower-inner quadrant of right male breast |
C50.322 | Malignant neoplasm of lower-inner quadrant of left male breast |
C50.329 | Malignant neoplasm of lower-inner quadrant of unspecified male breast |
C50.4 | Malignant neoplasm of upper-outer quadrant of breast |
C50.41 | Malignant neoplasm of upper-outer quadrant of breast, female |
C50.411 | Malignant neoplasm of upper-outer quadrant of right female breast |
C50.412 | Malignant neoplasm of upper-outer quadrant of left female breast |
C50.419 | Malignant neoplasm of upper-outer quadrant of unspecified female breast |
C50.42 | Malignant neoplasm of upper-outer quadrant of breast, male |
C50.421 | Malignant neoplasm of upper-outer quadrant of right male breast |
C50.422 | Malignant neoplasm of upper-outer quadrant of left male breast |
C50.429 | Malignant neoplasm of upper-outer quadrant of unspecified male breast |
C50.5 | Malignant neoplasm of lower-outer quadrant of breast |
C50.51 | Malignant neoplasm of lower-outer quadrant of breast, female |
C50.511 | Malignant neoplasm of lower-outer quadrant of right female breast |
C50.512 | Malignant neoplasm of lower-outer quadrant of left female breast |
C50.519 | Malignant neoplasm of lower-outer quadrant of unspecified female breast |
C50.52 | Malignant neoplasm of lower-outer quadrant of breast, male |
C50.521 | Malignant neoplasm of lower-outer quadrant of right male breast |
C50.522 | Malignant neoplasm of lower-outer quadrant of left male breast |
C50.529 | Malignant neoplasm of lower-outer quadrant of unspecified male breast |
C50.6 | Malignant neoplasm of axillary tail of breast |
C50.61 | Malignant neoplasm of axillary tail of breast, female |
C50.611 | Malignant neoplasm of axillary tail of right female breast |
C50.612 | Malignant neoplasm of axillary tail of left female breast |
C50.619 | Malignant neoplasm of axillary tail of unspecified female breast |
C50.62 | Malignant neoplasm of axillary tail of breast, male |
C50.621 | Malignant neoplasm of axillary tail of right male breast |
C50.622 | Malignant neoplasm of axillary tail of left male breast |
C50.629 | Malignant neoplasm of axillary tail of unspecified male breast |
C50.8 | Malignant neoplasm of overlapping sites of breast |
C50.81 | Malignant neoplasm of overlapping sites of breast, female |
C50.811 | Malignant neoplasm of overlapping sites of right female breast |
C50.812 | Malignant neoplasm of overlapping sites of left female breast |
C50.819 | Malignant neoplasm of overlapping sites of unspecified female breast |
C50.82 | Malignant neoplasm of overlapping sites of breast, male |
C50.821 | Malignant neoplasm of overlapping sites of right male breast |
C50.822 | Malignant neoplasm of overlapping sites of left male breast |
C50.829 | Malignant neoplasm of overlapping sites of unspecified male breast |
C50.9 | Malignant neoplasm of breast of unspecified site |
C50.91 | Malignant neoplasm of breast of unspecified site, female |
C50.911 | Malignant neoplasm of unspecified site of right female breast |
C50.912 | Malignant neoplasm of unspecified site of left female breast |
C50.919 | Malignant neoplasm of unspecified site of unspecified female breast |
C50.92 | Malignant neoplasm of breast of unspecified site, male |
C50.921 | Malignant neoplasm of unspecified site of right male breast |
C50.922 | Malignant neoplasm of unspecified site of left male breast |
C50.929 | Malignant neoplasm of unspecified site of unspecified male breast |
Malignant ascites | |
R18.0 | Malignant ascites |
Malignant neoplasm of the ovary | |
C56 | Malignant neoplasm of ovary |
C56.1 | Malignant neoplasm of right ovary |
C56.2 | Malignant neoplasm of left ovary |
C56.9 | Malignant neoplasm of unspecified ovary |
Malignant tumor of urinary bladder | |
C67 | Malignant neoplasm of bladder |
C67.0 | Malignant neoplasm of trigone of bladder |
C67.1 | Malignant neoplasm of dome of bladder |
C67.2 | Malignant neoplasm of lateral wall of bladder |
C67.3 | Malignant neoplasm of anterior wall of bladder |
C67.4 | Malignant neoplasm of posterior wall of bladder |
C67.5 | Malignant neoplasm of bladder neck |
C67.6 | Malignant neoplasm of ureteric orifice |
C67.7 | Malignant neoplasm of urachus |
C67.8 | Malignant neoplasm of overlapping sites of bladder |
C67.9 | Malignant neoplasm of bladder, unspecified |
Pericardial malignant effusions | |
I31.3 | Pericardial effusion (noninflammatory) |
Pleural malignant effusions | |
J91.0 | Malignant pleural effusion |
0-9 | A-Z |
---|---|
C50 | Malignant neoplasm of breast |
C50.1 | Malignant neoplasm of central portion of breast |
C50.11 | Malignant neoplasm of central portion of breast, female |
C50.111 | Malignant neoplasm of central portion of right female breast |
C50.112 | Malignant neoplasm of central portion of left female breast |
C50.119 | Malignant neoplasm of central portion of unspecified female breast |
C50.12 | Malignant neoplasm of central portion of breast, male |
C50.121 | Malignant neoplasm of central portion of right male breast |
C50.122 | Malignant neoplasm of central portion of left male breast |
C50.129 | Malignant neoplasm of central portion of unspecified male breast |
C50.2 | Malignant neoplasm of upper-inner quadrant of breast |
C50.21 | Malignant neoplasm of upper-inner quadrant of breast, female |
C50.211 | Malignant neoplasm of upper-inner quadrant of right female breast |
C50.212 | Malignant neoplasm of upper-inner quadrant of left female breast |
C50.219 | Malignant neoplasm of upper-inner quadrant of unspecified female breast |
C50.22 | Malignant neoplasm of upper-inner quadrant of breast, male |
C50.221 | Malignant neoplasm of upper-inner quadrant of right male breast |
C50.222 | Malignant neoplasm of upper-inner quadrant of left male breast |
C50.229 | Malignant neoplasm of upper-inner quadrant of unspecified male breast |
C50.3 | Malignant neoplasm of lower-inner quadrant of breast |
C50.31 | Malignant neoplasm of lower-inner quadrant of breast, female |
C50.311 | Malignant neoplasm of lower-inner quadrant of right female breast |
C50.312 | Malignant neoplasm of lower-inner quadrant of left female breast |
C50.319 | Malignant neoplasm of lower-inner quadrant of unspecified female breast |
C50.32 | Malignant neoplasm of lower-inner quadrant of breast, male |
C50.321 | Malignant neoplasm of lower-inner quadrant of right male breast |
C50.322 | Malignant neoplasm of lower-inner quadrant of left male breast |
C50.329 | Malignant neoplasm of lower-inner quadrant of unspecified male breast |
C50.4 | Malignant neoplasm of upper-outer quadrant of breast |
C50.41 | Malignant neoplasm of upper-outer quadrant of breast, female |
C50.411 | Malignant neoplasm of upper-outer quadrant of right female breast |
C50.412 | Malignant neoplasm of upper-outer quadrant of left female breast |
C50.419 | Malignant neoplasm of upper-outer quadrant of unspecified female breast |
C50.42 | Malignant neoplasm of upper-outer quadrant of breast, male |
C50.421 | Malignant neoplasm of upper-outer quadrant of right male breast |
C50.422 | Malignant neoplasm of upper-outer quadrant of left male breast |
C50.429 | Malignant neoplasm of upper-outer quadrant of unspecified male breast |
C50.5 | Malignant neoplasm of lower-outer quadrant of breast |
C50.51 | Malignant neoplasm of lower-outer quadrant of breast, female |
C50.511 | Malignant neoplasm of lower-outer quadrant of right female breast |
C50.512 | Malignant neoplasm of lower-outer quadrant of left female breast |
C50.519 | Malignant neoplasm of lower-outer quadrant of unspecified female breast |
C50.52 | Malignant neoplasm of lower-outer quadrant of breast, male |
C50.521 | Malignant neoplasm of lower-outer quadrant of right male breast |
C50.522 | Malignant neoplasm of lower-outer quadrant of left male breast |
C50.529 | Malignant neoplasm of lower-outer quadrant of unspecified male breast |
C50.6 | Malignant neoplasm of axillary tail of breast |
C50.61 | Malignant neoplasm of axillary tail of breast, female |
C50.611 | Malignant neoplasm of axillary tail of right female breast |
C50.612 | Malignant neoplasm of axillary tail of left female breast |
C50.619 | Malignant neoplasm of axillary tail of unspecified female breast |
C50.62 | Malignant neoplasm of axillary tail of breast, male |
C50.621 | Malignant neoplasm of axillary tail of right male breast |
C50.622 | Malignant neoplasm of axillary tail of left male breast |
C50.629 | Malignant neoplasm of axillary tail of unspecified male breast |
C50.8 | Malignant neoplasm of overlapping sites of breast |
C50.81 | Malignant neoplasm of overlapping sites of breast, female |
C50.811 | Malignant neoplasm of overlapping sites of right female breast |
C50.812 | Malignant neoplasm of overlapping sites of left female breast |
C50.819 | Malignant neoplasm of overlapping sites of unspecified female breast |
C50.82 | Malignant neoplasm of overlapping sites of breast, male |
C50.821 | Malignant neoplasm of overlapping sites of right male breast |
C50.822 | Malignant neoplasm of overlapping sites of left male breast |
C50.829 | Malignant neoplasm of overlapping sites of unspecified male breast |
C50.9 | Malignant neoplasm of breast of unspecified site |
C50.91 | Malignant neoplasm of breast of unspecified site, female |
C50.911 | Malignant neoplasm of unspecified site of right female breast |
C50.912 | Malignant neoplasm of unspecified site of left female breast |
C50.919 | Malignant neoplasm of unspecified site of unspecified female breast |
C50.92 | Malignant neoplasm of breast of unspecified site, male |
C50.921 | Malignant neoplasm of unspecified site of right male breast |
C50.922 | Malignant neoplasm of unspecified site of left male breast |
C50.929 | Malignant neoplasm of unspecified site of unspecified male breast |
C56 | Malignant neoplasm of ovary |
C56.1 | Malignant neoplasm of right ovary |
C56.2 | Malignant neoplasm of left ovary |
C56.9 | Malignant neoplasm of unspecified ovary |
C67 | Malignant neoplasm of bladder |
C67.0 | Malignant neoplasm of trigone of bladder |
C67.1 | Malignant neoplasm of dome of bladder |
C67.2 | Malignant neoplasm of lateral wall of bladder |
C67.3 | Malignant neoplasm of anterior wall of bladder |
C67.4 | Malignant neoplasm of posterior wall of bladder |
C67.5 | Malignant neoplasm of bladder neck |
C67.6 | Malignant neoplasm of ureteric orifice |
C67.7 | Malignant neoplasm of urachus |
C67.8 | Malignant neoplasm of overlapping sites of bladder |
C67.9 | Malignant neoplasm of bladder, unspecified |
I31.3 | Pericardial effusion (noninflammatory) |
J91.0 | Malignant pleural effusion |
R18.0 | Malignant ascites |